Hematology/Oncology

Top Story

Advanced care planning rates increase modestly among patients with cancer

September 4, 2015

Read the Perspective from Christine A. Zawistowski, MD

The use of advanced care planning among patients with cancer increased modestly between 2000 and 2012, according to an analysis of prospectively collected survey data.

A significant increase in the designation of a durable power of attorney accounted for most of the increase. Researchers observed no significant changes in use of end-of-life discussions or living wills.

New ACA rule aims to protect patients from sex, disability discrimination

September 4, 2015
The HHS has announced a proposed rule to modify discrimination provisions of the Affordable Care Act, which would help provide equal access to health care and coverage…
Robert L. Coleman, MD In the Journals

Bisphosphonates improve breast cancer survival in postmenopausal women

September 4, 2015
Adjuvant treatment with bisphosphonates reduced the rate of breast cancer recurrence in the bone and improved breast-cancer survival among women who were postmenopausal…
In the Journals

Extent of lymphadenectomy may not influence survival in esophageal cancer

September 3, 2015
The number of lymph nodes removed during lymphadenectomy may not influence 5-year all-cause or disease-specific survival among patients with esophageal cancer, according…
In the Journals

Simulation model provides more accurate estimate of cancer progression in Barrett's esophagus

September 3, 2015
Simulation modeling revealed that the lower estimates of the rate of progression from Barrett’s esophagus to esophageal adenocarcinoma from population-based…
More News Headlines »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »
Meeting News Coverage Video
VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

August 20, 2015
CHICAGO — The PALOMA-3 trial, which evaluated the addition of palbociclib to fulvestrant, demonstrated…
More »
CME
Hematology Oncology Case Consults

The Patient with Multiple Myeloma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with multiple myeloma.
More »
morganatic-roan
morganatic-roan